Pharmaceutical company owners merged with FMCG market leader

At the end of October Maspex Wadowice Group purchased shares in Sequoia sp. z o.o. from a minority shareholder, Sorabot investment fund. Our Law Firm acted for the Sequoia majority shareholders, who were the driving force behind the company’s market success and are currently continuing their work.

In the transaction DZP’s lawyers drew up draft transaction documentation for the client (share purchase and other agreement) and negotiated the transaction terms and documentation. The advice was provided by experts in our Corporate and M&A Practice, Robert Niczyporuk, Piotr Andrzejczak and Jakub Wieszczeczyński, and Marcin Matczak and Tomasz Kaczyński from our Life Sciences Practice.

The good reputation of Sequoia and its products on the pharmaceutical market and Maspex Group’s unquestioned position on the FMCG market mean that the transaction fits in to the dynamic development strategies of both companies.

Sequoia specialises in selling functional foods (dietary supplements, food for special medicinal purposes) for the most sensitive of consumer groups – babies, children and pregnant women. The company’s offer also covers an extensive portfolio of products for dietary management.

Maspex Wadowice Group is one of the largest food companies in Central and Eastern Europe.